🇺🇸 FDA
Company

LISATA

LISATA THERAPEUTICS, INC.

LSTA pharma USA

Quick answer

LISATA is a pharma company (LSTA) headquartered in BASKING RIDGE, NJ, USA with 15 tracked pipeline programs.

Pipeline (15)

project

Auto-CD34+ cells

Chronic Myocardial Ischemia

Phase 3 · mab · completed

1 trials project

Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC)

Stage IV Melanoma

Phase 3 · mab · terminated

1 trials project

CLBS03 Low Dose

Diabetes Mellitus

Phase 2 · mab · completed

1 trials project

CLBS12

Critical Limb Ischemia

Phase 2 · mab · completed

1 trials project

CLBS14 (low-dose)

Myocardial Ischemia

Phase 2 · mab · completed

1 trials project

CLBS16

Coronary Microvascular Dysfunction

Phase 2 · mab · terminated

2 trials project

NBS10

ST Segment Elevation Myocardial Infarction

Phase 2 · mab · completed

1 trials project

certepetide

Pancreas Cancer

Phase 2 · small_molecule · terminated

1 trials project

certepetide

Cholangiocarcinoma

Phase 2 · small_molecule · active

1 trials project

lymphokine-activated killer cells

Brain and Central Nervous System Tumors

Phase 2 · mab · terminated

1 trials project

therapeutic autologous dendritic cells

Melanoma (Skin)

Phase 2 · mab · completed

1 trials project

Biological/Vaccine: therapeutic autologous dendritic cells.

Kidney Cancer

Phase 1 · mab · terminated

1 trials project

CEND-1

Pancreatic Cancer

Phase 1 · small_molecule · completed

1 trials project

CLBS119

Covid-19

Phase 1 · mab · terminated

1 trials project

CLBS201

Chronic Kidney Diseases

Phase 1 · small_molecule · completed

1 trials

Patents (1)

patent

US 12351653

Pharmaceutical compositions comprising novel cyclic peptides

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)